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Abstract
Background: Solitary involvement of the sphenoid sinus has rarely been reported in non-
Hodgkin's lymphoma. Isolated oculomotor nerve palsy is uncommon as an initial presentation of
malignant tumors of the sphenoid sinus.
Case presentation: A 53-year-old woman presented with a three-month history of headache and
diplopia. Neurological examination revealed complete left oculomotor nerve palsy. Magnetic
Resonance Imaging (MRI) demonstrated a homogenous soft-tissue lesion occupying the left
sphenoid sinus and invading the left cavernous sinus. The patient underwent transsphenoidal biopsy
and the lesion was histologically diagnosed as non-Hodgkin's lymphoma, diffuse large B-cell type.
Tumor cells were positive for CD20 and negative for CD3. Following six cycles of chemotherapy,
the left oculomotor nerve palsy that had been previously observed was completely resolved. There
was no enhancing lesion noted on follow-up MRI.
Conclusion: It is important to recognize that non-Hodgkin's lymphoma of the sphenoid sinus can
present with isolated oculomotor nerve palsy, although it is extremely rare. The cranial nerve
deficits can resolve dramatically after chemotherapy.
Background
Approximately 10–34% of all non-Hodgkin's lymphomas
arise from extranodal sites [1-3]. Of these, nasal or para-
nasal lymphomas account for less than 3% of all malig-
nant extranodal lymphomas [4]. The sphenoid sinus is a
rare primary site for extranodal lymphomas; only a few
case reports exist in the literature [5-10]. Clinical signs and
symptoms of malignant lymphomas of the paranasal
sinuses include a mass in the nasal cavity, facial pain, par-
esthesia, recurrent sinusitis, nasal discharge, eyelid swell-
ing, and proptosis if orbital invasion has occurred [10].
Isolated oculomotor nerve palsy is a rare complication of
cavernous sinus invasion in non-Hodgkin's lymphomas.
We report a case of isolated oculomotor nerve involve-
ment presenting in a woman with non-Hodgkin's lym-
phoma originating from the sphenoid sinus. This case
demonstrates the resolution of oculomotor nerve palsy
after chemotherapy.
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A 53-year-old woman presented to the Neurology outpa-
tient office with a three-month history of headache and
diplopia. There was no history of fever, weight loss, or noc-
turnal sweating. The patient had no history of diabetes,
hypertension, or neurological diseases and no risk factors
for stroke. No cervical bruits or lymphadenopathy in the
cervical, supraclavicular or axillary areas were appreciated.
Neurological examination revealed complete left occulo-
motor nerve palsy, with ptosis, mydriasis and outward
positioning of the left eye. The remaining results of the
physical examination were within normal limits. All serum
laboratory and hormonal values were within the normal
ranges.
MRI demonstrated a homogenous soft-tissue lesion occu-
pying the left sphenoid sinus and invading the left cavern-
ous sinus (Figure 1). The mass was homogenously
enhanced by Gadolinium injection, and no intradural
extension of the tumor was noted. A space-occupying
lesion in the sphenoid sinus, such as a carcinoma,
mucocele, or ectopic pituitary adenoma, was suspected as a
preliminary diagnosis.
During the open surgery, the left sphenoid sinus con-
tained a red friable vascular tumor, which was biopsied.
Frozen sections of an intrasurgical biopsy were diagnosed
as compatible with a small round cell tumor. The final
histological diagnosis was non-Hodgkin's lymphoma, dif-
fuse large B-cell type, which has uniform, round-to-oval
nuclei with vesicular chromatin and one or multiple con-
spicuous nucleoli. These tumor cells were positive for
CD20 and negative for CD3 (Figure 2).
The patient was referred to medical oncology for a staging
work-up, including bone marrow biopsy and positron
emission tomography (PET), all of which were negative.
The patient received chemotherapy consisting of eight
cycles of CHOP (cyclophosphamide, adriamycin, vincris-
tine (oncovin), and prednisone) with adjuvant Rituxi-
mab. Following six cycles of chemotherapy, the previously
observed left third nerve palsy was completely resolved.
There was no enhancing lesion noted on follow-up MRI 6
months postsurgery (Figure 3). The patient is currently
under regular follow-up monthly in the medical oncology
clinic.
Discussion
This case study is unique in two aspects: the initial clinical
presentation of isolated oculomotor nerve palsy without
any additional neurologic deficits is rare, and the nature of
the tumor, which occupied the sphenoid sinus, is a rarely
documented site of non-Hodgkin's lymphoma. To our
knowledge, there have been only six documented cases of
primary sphenoidal non-Hodgkin's lymphoma in the liter-
ature. The clinical characteristics of these cases are summa-
rized in Table 1. There have been a total of six males and
one female documented in the literature, including our
case. The median age was 48 years (range 5–78). Presenting
symptoms included headache, visual disturbance and cra-
nial nerve involvement.
All reported cases had cranial nerve deficits with the sixth
cranial nerve being the nerve most commonly affected
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A: Photomicrograph demonstrating non-Hodgkin's lym-
phoma of the diffuse large B-cell type, which has uniform, 
round-to-oval nuclei with vesicular chromatin and one or 
multiple conspicuous nucleoli (H & E, original magnification × 
200). B: These tumor cells are positive for CD20 (Original 
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one of the earliest signs of a diseased sphenoid. This
involvement is attributed to the long, medial intracavern-
ous position of the abducens. Lawson et al., [11] reported
sixth nerve involvement in 6% of inflammatory cases and
in 50% of neoplastic cases of isolated sphenoid sinus dis-
ease, with equal incidence for both benign and malignant
tumors. The oculomotor nerve was the second most
affected, as demonstrated by our case [7]. Involvement of
the trigeminal nerve is via the first and second divisions,
producing retrobulbar pain and midfacial pain and
numbness [10]. With regard to the total incidence of
objective cranial nerve deficits, these symptoms are
directly related to the extent of the lesions.
Radiological imaging is vital in many aspects, including
assessment of tumor extension, assessment of bony
destruction, evidence of mucosal thickening, and choice of
the best biopsy site and route. Although computed tomog-
raphy (CT) is the best technique to demonstrate fine bony
detail, MRI can adequately assess most areas of bony
destruction and has a number of additional advantages.
MRI can also more easily distinguish a tumor from mucosal
thickening or retained sinus secretions [12]. Extension into
surrounding spaces and into the cranial fossa is more easily
evaluated in coronal and sagittal images. Bone remodeling
and mucosal thickening are associated with chronic
inflammatory disease, especially if a mucocele is present.
Bone erosion is found principally with neoplastic disease,
occurring rarely with mucoceles [11]. Extension is associ-
ated with malignant tumors. The reported isolated sphe-
noid sinus disease incidence is listed in Table 2[11,13-15].
Non-Hodgkin's lymphomas involving the sphenoid sinus
are rarely considered in the differential diagnosis of a mass
involving the sphenoid sinus without other systemic man-
ifestations such as weight loss, night sweating or fever. This
is probably due to the exceedingly rare incidence of this dis-
ease.
It is unlikely for T-lymphomas to involve the nasal cavity
because most paranasal lymphomas are B-cell tumors
[16,17]. Only one report exists on the histological and
clinical features of sphenoid sinus T-cell lymphoma [10].
Others studies, including our case, were confirmed as dif-
fuse, large B-cell lymphomas. The primary site of the lym-
phoma together with its histologic grade, T/B phenotype
and clinical stage may be important prognostic factors in
primary non-Hodgkin's lymphoma of the sinonasal cavi-
ties [18]. These lymphomas have a poor prognosis which
is usually worse than that associated with lymphomas in
other sites in the body [19].
Non-Hodgkin's lymphomas are frequently treated with,
and respond to, a combination of chemotherapy and radi-
otherapy. A review of several reports suggests that the best
treatment outcomes are obtained with the CHOP (cyclo-
phosphamide, adriamycin, vincristine (oncovin), and
prednisone) regimen, given at three-week intervals [20].
Rituximab is a therapeutic antibody directed against the
CD20 surface antigen, which is frequently present in lym-
phoma cells. Its use in conjunction with CHOP augments
a treatment response in lymphomas expressing the CD20
antigen, as seen in our case [21]. Chemotherapy is fre-
quently followed by loco-regional radiotherapy at a dose of
30 to 40 Gy [15]. In our case the oculomotor nerve palsy
was dramatically improved over the course of chemother-
apy.
Conclusion
To our knowledge, there have been only six documented
cases of primary sphenoidal non-Hodgkin's lymphoma. It
is important to recognize that non-Hodgkin's lymphoma
of the sphenoid sinus can present with isolated oculomotor
Table 1: Clinical characteristics of patients with primary sphenoidal non-Hodgkin lymphoma previously described in the literature
Age (yrs)/sex Clinical symptoms and signs Local extension Pathology Treatment Reference
52/M Reduced visual acuity, diplopia, 
retroorbital pain Orbital apex 
syndrome with blindness
Left optic canal Diffuse large B cell 
type
Radiotherapy 
Chemotherapy
Ueba et al [15]
39/M Nasal congestion, facial pain, 
paresthesia
Sellar turcica Diffuse large T cell 
type
Radiotherapy CHOP-
M
Weber and 
Loewenheim [16]
44/M Diplopia, bilateral abducens 
nerve palsy
Clivus, cavernous 
sinus, ethmoid sinus
Diffuse large B cell 
type
CHOP-M Deleu et al [3]
78/M Diplopia, abducens nerve palsy Clivus, cavernous 
sinus
Diffuse large B cell 
type
Radiotherapy (45 Gy) Ferrario et al [4]
5/M Sudden visual loss, optic 
neuropathy
Suprasellar cavernous 
sinus
Diffuse large B cell 
type
Radiotherapy (60 Gy) 
Chemotherapy*
Roth and Siatkowski 
[12]
64/M Headache, diplopia, 
oculomotor nerve palsy
Sellar turcica, 
cavernous sinus
Diffuse large B cell 
type
COPPA-M 
Radiotherapy (50 Gy)
Metellus et al [8]
53/F Headache, ptosis, oculomotor 
nerve palsy
Cavernous sinus Diffuse large B cell 
type
CHOP-R Present case
* CHOP-M = cyclophosphamide, adriamycin, vincristine, prednisone, and methotrexate; CHOP-R = cyclophosphamide, adriamycin, vincristine, 
prednisone, and rituximab; COPPA-M = cyclophosphamide, Oncovin, procarbazine, prednisone, adriamycin, and methotrexate.Page 3 of 4
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nerve palsy, although it is extremely rare. The cranial nerve
deficits can be dramatically resolved following chemother-
apy.
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Table 2: Classification of isolated sphenoid sinus disease
Inflammatory disease Benign neoplasms Malignant neoplasms
Sinusitis acute/chronic Inverting 
papilloma
Squamous cell 
carcinoma
Mucocele Pseudotumor Adenoid cystic 
carcinoma
Polyps retention cyst Myxofibroma Chondrosarcoma
Fungal sinusitis Schwannoma Neuroendocrine 
carcinoma
Osteochondroma Mucoepidermoid 
carcinoma
Plasmacytoma Malignant fibrous 
histiocytoma
Chordoma Osteogenic sarcoma
Pituitary 
adenoma
Lymphoma
Meningioma Olfactory 
neuroblastoma
Epidermoid 
tumor
Ewing's sarcoma
Cavernous 
hemangioma
Giant cell tumor
Metastatic tumorsPage 4 of 4
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